维普期刊资源整合服务平台（V6.5）

42篇 您的检索式：作者名="Herman JH"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	RhlG for the treatment of immune thrombocytopenia : consensus and controversy (CME) 显示文摘	Despotovic JM Lambert MP Herman JH	2012	Transfusion2012，52，5：	1
2	Repeat gamma knife radiosurgery for refractory or recurrent trigeminal neuralgia:treatment outcomes and quality-of-life assessment显示文摘	Herman JM Petit JH Amin P	2004	Int J Radiat Oncol Biol Phys2004，59，1：	1
3	Polymethylmethacry late-induced releaseof bone-resorbing factors显示文摘	〔4〕 Herman JH Sowder WG Anderson D	1989	J Bone Joint Surg1989，，：	1
4	RhIG for the treatment of immune thromboeytopenia: consensus and controversy (CME) 显示文摘	DESPOTOVIC JM LAMBERT MP HERMAN JH	2012	Transfusion2012，52，5：	1
5	Risk of cardiovascular disease events in patients with type 2 diabetes prescribed the glucagon- like peptide I(GLP-1) receptor agonist exenatide twice daily or other glucose-lowering therapies: a retrospective analysis of the LifeLink database显示文摘	Best JH Hoogwerf B J Herman WH	2011	Diabetes Care2011，34，1：	1
6	Risk of cardiovasculardisease events in patients with type 2 diabetes prescribed the glucagon-like peptide 1 (GLP-1) receptor agonist exenatide twice daily or otherglucose-lowering therapies a retrospective analysis of the LifeLinkdatabase显示文摘	Best JH Hoogwerf BJ Herman WH	2011	Diabetes Care2011，34，1：	1
7	Hypertrophic pachymeningitis in rheumatoid arthritis after adalimumab administration显示文摘	Ahmed M Luggen M Herman JH	2006	J Rheumatol2006，33，11：	1
8	Polymethylmethacrylate-induction,release of bone-resorbing failures显示文摘	Herman JH Sowder WG Anderson D	1989	J Bone Joint Surg AM1989，71，10：	1
9	Risk of cardiovascular disease events in patients with type 2 diabetes prescribed the glucagon-like peptide 1 (GLP-1) receptor agonist exenatide twice daily or other glucose-lowering therapies: a retrospective analysis of the lifeline database 显示文摘	Best JH Hoogwerf B J Herman WH	2011	Diabetes Care2011，34，1：	1
10	Risk of cardiovascular disease events in patients with type 2 diabetes prescribed the glucagon- like peptide I(GLP-1) receptor agonist exenatide twice daily or other glucose-lowering therapies: a retrospective analysis of the Life Link database显示文摘	Best JH Hoogwerf B J Herman WH	2011	Diabetes Care2011，34，1：	1
11	Epidemiology of stroke in Tilberg, the Netherlands显示文摘	Herman B Schulte BPM Van Luijk JH	1980	Stroke1980，11，：	1
12	Maximum likelihood estimation of receiver operating characteristic (ROC) curves from continuously-distributed data显示文摘	Metz CE Herman BA Shen JH	1998	Stat Med1998，17，9：	1
13	Maximum-likelihood estimation of receiver operating characteristic(ROC) curves from continuously-distributed data显示文摘	Herman BA Shen JH	1998	Statistics in Medicine1998，17，9：	1
14	Risk of cardiovascular disease events in patients with type 2 diabetes prescribed the glucagon-like peptide 1 (GLP-1) receptor agonist exenatide twice daily or other glucose-lowering therapies:a retrospective analysis of the LifeLink database显示文摘	Best JH Hoogwerf BJ Herman WH		0，，01：	1
15	Risk of cardio- vascular disease events in patients with type 2 diabetes pre- scribed the glucagon-like peptide 1 (GLP-1) receptor agonist exenatide twice daily or other glucose-lowering therapies: a retrospective analysis of the LifeLink database 显示文摘	Best JH Hoogwerf B J Herman WH	2011	Diabetes Care2011，34，1：	1
16	Risk of cardiovascular disease events in patients with type 2 diabetes prescribed the glucagon-like peptide 1 (GLP-1) receptor agonist exenatide twice daily or other glucose-lowering therapies: a retrospective analysis of the LifeLink database显示文摘	Best JH Hoogwerf BJ Herman WH	2011	Diabetes Care2011，34，：	1
17	Maximum-likelihood estimation of receiver operating characteristic(ROC) curves from continously-distributed data显示文摘	Metz CE Herman BA Shen JH		0，，：	1
18	Caspases,apoptosis and aging显示文摘	Zhang JH Zhong YP Herman B	2003	Ageing research reviews2003，2，：	1
19	Risk of cardiovascular diseaseevents in patients with type 2 diabetes prescribed the glucagon-like pep-tide 1(GLP-1)receptor agonist exenatide twice daily or other glucoselowering therapies:a retrospective analysis of the LifeLink database显示文摘	Best JH Hoogwerf BJ Herman WH	2011	Diabetes Care2011，34，1：	1
20	Risk of cardio- vascular disease event in patients with type 2 diabetes prescribed the glucagon-like peptide 1 (GLP-1) receptor agonist exenatide twice daily or other glucose-lowering therapies : a retrospective analysis of the life link database 显示文摘	Best JH Hoogwerf BJ Herman WH	2011	Diabetes Care2011，34，1：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示